Form 4 · Filed Mar 11, 2026, 12:00 PM UTC
ATRA/Atara Biotherapeutics, Inc.
Grant-Huerta Yanina — Chief Accounting Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | A | other | 20,300 | $0 | — | 52,050 |
Source: SEC EDGAR raw filing ↗ · Accession 0000905148-26-001224